Derivatives Service Bureau

Derivatives Service Bureau

The Derivatives Service Bureau (DSB) Consortium Limited is a global numbering agency specializing in the allocation and maintenance of International Securities Identification Numbers (ISINs), Classification of Financial Instruments (CFIs), and Financial Instrument Short Names (FISNs) for Over-the-Counter (OTC) derivatives. Founded by the Association of National Numbering Agencies (ANNA) in 2015, the DSB operates as a fully automated, centralized global utility designed to meet the complex identification needs of OTC derivatives markets. Its primary role is to facilitate market participants and regulators by providing unique and internationally recognized identifiers for derivatives products, enhancing transparency and stability in the derivatives markets worldwide.

DSB’s services support regulatory compliance and market efficiency by enabling standardized and consistent product identification used in transaction reporting, risk assessment, and market surveillance. In 2019, the Financial Stability Board designated the DSB as the exclusive service provider for the Unique Product Identifier (UPI) system, broadening its role to include management of the UPI reference data library. This designation highlights its critical contribution to systemic risk assessment and detecting market abuse in OTC derivatives trading.

The consortium works on a cost-recovery basis, providing services globally with widespread industry representation and collaboration at its core. It employs a Technology Advisory Committee comprised of user organizations, independent experts, and regulatory observers to ensure technology strategies align with market requirements. DSB’s technological platform supports multiple taxonomies and delivers near-real-time issuance of identifiers, integrating with front-office systems to facilitate trading and order management.

The DSB fosters transparency and operational risk control for institutional investors by providing consistent identifiers in OTC derivatives markets, supporting regulatory reporting and market integrity. It maintains operational offices in London, UK, and is a legal subsidiary of ANNA. The company files annual statutory accounts audited according to UK financial standards, reporting its activities segmented into ISIN, commercial optional services, and UPI systems.

In recent years, DSB has actively engaged in industry consultations to refine cost allocation policies, ensure fair data access, and introduce new user categories like fee-paying distributors to enhance service models for 2026 and beyond. The consortium’s proactive approach reflects its commitment to supporting the evolving global regulatory framework for derivatives markets while maintaining broad industry support and transparency.

  • Company Name: Derivatives Service Bureau (DSB) Consortium Limited

  • Founded: 2015 (Company incorporated 2016)

  • Headquarters: London, United Kingdom

  • Registration Number: 10542063 (UK Companies House)

  • Industry: Information Services, Information Technology Consultancy

  • Website: https://www.anna-dsb.com

  • Legal Status: Private Limited Company, Subsidiary of ANNA

  • Employees: 11-50

No related lobbyists found.

  • Financial Services

  • Information Technology Services

  • Regulatory Affairs

  • Market Infrastructure Utilities

  • Data Standardization and Compliance

  • Association of National Numbering Agencies (ANNA) (Parent Organization)

  • Financial Stability Board (FSB)

  • Industry user organizations in OTC derivatives markets

  • Regulatory bodies involved in derivatives market oversight

  • Technology Advisory Committee (with representatives from user organizations, independent experts, regulatory observers)

  • Standard-setting bodies related to financial instruments (ISO)

Specific, detailed financial data regarding lobbying expenditures of the Derivatives Service Bureau (DSB) Consortium Limited since its registration with the EU Register is not publicly available in the sourced materials or EU Transparency Register as of June 2025.

  • Registered in the EU Transparency Register as a lobbying entity (implied but exact registration details need EU register verification)

  • Engages with EU regulatory institutions regarding OTC derivatives regulatory framework, data standardization, and reporting guidelines.

Records of all meetings conducted by the DSB lobbying firm since registration with the EU Register up until June 2025 are not publicly detailed in accessible sources. Engagements likely include consultations and meetings with financial regulators, European Commission departments overseeing financial markets, and industry stakeholders, but specific logs have not been retrieved.